Bicalutamide 150mg Film-Coated Tablets
PACKAGE LEAFLET: INFORMATION FOR THE USER Bicalutamide 150 mg film-coated tablets.
Bicalutamide
Read all of this leaflet carefully before you start taking this medicine.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you. Do not pass it on to others. It may harm them,
even if their symptoms are the same as yours.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet:
1. What Bicalutamide 150 mg is and what it is used for
2. Before you take Bicalutamide 150 mg
3. How to take Bicalutamide 150 mg
4. Possible side effects
5. How to store Bicalutamide 150 mg
6. Further information
1. WHAT BICALUTAMIDE 150 mg IS AND WHAT IT IS USED FOR
Bicalutamide 150 mg can be used alone but can also be given as part of a combination treatment to patients that have had their prostate removed. Additionally in combination with radiation therapy for the treatment of prostate cancer, whereby the cancer has spread from the capsule of the prostate gland to the close surrounding tissue. These patients are at high risk for the cancer to spread.
The active ingredient of Bicalutamide 150 mg, bicalutamide, belongs to a group of medicines called non-steroidal anti-androgens. It blocks the undesired effect of a chemical made by a male sex gland (androgens) and inhibits cell growth in the prostate in this way.
2. BEFORE YOU TAKE BICALUTAMIDE 150 mg Do not take Bicalutamide 150 mg
- if you are allergic (hypersensitive) to bicalutamide or any of the other ingredients of Bicalutamide 150 mg
- if you are already taking terfenadine or astemizole (for hay fever or allergy), or cisapride (for stomach disorders).
Bicalutamide 150 mg should not be taken by women or must not be given to children or adolescents.
Take special care with Bicalutamide 150 mg
- if your liver function is moderately or severely impaired. The drug should then only be taken after your doctor has carefully considered possible benefits and risks. If this is the case, your doctor will regularly perform tests of liver function. If severe disturbances to liver function develop, treatment with bicalutamide should be discontinued.
- if your renal function is severely impaired. The drug should then only be taken after your doctor has carefully considered possible benefits and risks.
- if you suffer from heart disease. If this is the case, your doctor should regularly monitor your heart function.
- if your blood still shows high levels of a certain protein used to detect prostate cancer and the disease is still getting worse, bicalutamide treatment may need to be stopped.
Taking other medicines
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
If you take Bicalutamide 150 mg together with one of the following medicines, the effect of bicalutamide as well as the other medicine may be influenced. Please speak to your doctor before taking any of these medicines together with Bicalutamide 150 mg:
- warfarin or any similar medicine to prevent blood clots,
- terfenadine or astemizole (for hay fever or allergy),
- cisapride (for stomach disorders),
- cyclosporin (used to suppress your immune system to prevent and treat rejection of a transplanted organ or bone marrow),
- calcium channel blockers (used to treat high blood pressure or some heart conditions)
- cimetidine (used to treat stomach ulcers),
- ketoconazole (used to treat fungal infections of the skin and nails).
Taking Bicalutamide 150 mg with food and drink
Bicalutamide 150 mg can be taken before, during or after a meal, but also you can take them without food. The film-coated tablet should be swallowed with some water or another liquid.
Pregnancy and breast-feeding
Bicalutamide 150 mg is contra-indicated in females and must not be given to pregnant or breastfeeding mothers.
Bicalutamide 150 mg may induce a period of subfertility or infertility in man.
Driving and using machines
Bicalutamide 150 mg is unlikely to adversely affect your ability to drive a car or to operate machinery. However, some people may occasionally feel dizzy or drowsy after taking Bicalutamide 150 mg. If you suffer from dizziness or drowsiness you would be best advised not to carry out such tasks. However if you still drive a car or use machines you should exercise extra caution.
Important information about some of the ingredients of Bicalutamide 150 mg
Bicalutamide 150 mg contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, such as lactose, contact your doctor immediately.
3. HOW TO TAKE BICALUTAMIDE 150 mg
Always take Bicalutamide 150 mg exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. The usual dose is one film-coated tablet daily. It is better to take the tablet at the same time every day. The film-coated tablet should be swallowed with some water or another liquid without being chewed and can be taken with or without food.
Children and adolescents
This medicine is not recommended for patients under the age of 18 years.
If you take more Bicalutamide 150 mg than you should
If you take more than your normal dose, contact your doctor. In the case of an overdose, contact the nearest hospital immediately. If possible, take your film-coated tablets or the box with you to show the doctor what you have taken.
If you forget to take Bicalutamide 150 mg
If you forget to take your medicine, take your dose when you remember and then take your next dose at the usual time. Do not take a double dose to make up for a frogotten dose. If you are worried, ask your doctor or pharmacist for advice.
If you stop taking Bicalutamide 150 mg
Do not stop taking your film-coated tablets, even if you are feeling well, unless your doctor tells you.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, Bicalutamide 150 mg can cause side effects, although not everybody gets them.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Side effects that are very common (estimated frequency is more than 1 person out of 10):
• rash
• gynaecomastia (development of breast in men)
• breast tenderness
• weakness
Side effects that are common (estimated frequency is less than 1 person out of 10 but more than 1 out of 100):
• anaemia
• dizziness
• somnolence
• hot flush
• abdominal pain
• constipation
• indigestion
• flatulence
• nausea
• alopecia
• hirsutism (hairiness) / hair re-growth
• dry skin
• itching
• blood in urine
• impotence (erectile dysfunction)
• chest pain
• oedema
• decreased appetite
• decreased libido
• depression
• hepatotoxicity
• jaundice
• increased of liver proteins
• weight gain
Side effects that are uncommon (estimated frequency is less than 1 person out of 100 but more than 1 out of 1000):
• hypersensitivity
• angioedeme (skin blistering)
• urticaria
• inflammation of the lungs called interstitial lung disease
Side effects that are rare (estimated frequency is less than 1 person out of 1000 but more than 1 out of 10,000)
• liver failure
If you notice any side effect not mentioned in this leaflet, please inform your doctor or pharmacist.
5. HOW TO STORE BICALUTAMIDE 150 mg
Keep out of the reach and sight of children.
This medicinal product does not require any special storage conditions.
Do not use Bicalutamide 150 mg after the expiry date which is stated on theblister and carton. The expiry date refers to the last day of that month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
6. FURTHER INFORMATION What Bicalutamide 150 mg contains
- The active substance is bicalutamide. Each film-coated tablet contains 150mg bicalutamide.
The other ingredients are:
Tablet core:
Lactose monohydrate, Povidone K-25, Sodium starch glycolate Type A, Magnesium Stearate. Film coating:
Opadry OY-S-9622 which contains Hypromellose 5 cP (E464), Titanium dioxide (E171) and Propylene Glycol.
What Bicalutamide 150 mg looks like and contents of the pack
Bicalutamide 150 mg is supplied as white, round, biconvex film-coated tablets with a score line on one side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal parts.
The film-coated tablets are packed in blister packs containing 10, 28, 30, and 90 tablets contained in a carton.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Hikma Farmaceutica S.A., Estrada do Rio da Mo 8, 8A e 8B - Ferven?a - 2705-906, Terrugem SNT, Portugal
Manufacturer
Genepharm S.A
18th klm Marathonos Avenue,
153 51 Pallini Attikis Greece
This medicinal product is authorised in the Member States of the EEA under the following names:
AT: Bicalutamid Hikma DE: Ribocadex IT: Bicalutamide Hikma PT: Bicalutamide Hikma UK: Bicalutamide
This leaflet was last approved in 09/2016.